Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We reaffirm our Neutral recommendation on Polycom Inc. ( PLCM - Analyst Report ) based on its current valuation, which plummeted 55% in the last year. The company’s second quarter of 2012 financial results missed the Zacks Consensus Estimates. The unified collaborative solutions market is becoming immensely competitive day by day and Polycom is yet to fix its sales execution problems in the North American region.
The global macro economy is growing at a very slow pace, resulting in uneven tech spending. Further, Polycom currently is in the midst of its transition from hardware-centric to cloud- and software-centric business model, which is the main reason behind its sales execution problems. Nevertheless,we believe Polycom’s decision to sale its enterprise handset business will be fruitful in the long term as the company is slowly disinvesting its non-core hardware businesses. In our view, Polycom is currently fairly valued.
At present, a major concern for Polycom is its lukewarm performance in the most important North American regions. The problem seems to be double-edged (1) growing competitive pressure (2) precipitous macro-economic fluctuations, resulting in volatile tech spending.
The uniform collaborative communications market is fiercely competitive, resulting in a cut-throat pricing strategy. Cisco Systems Inc. ( CSCO - Analyst Report ) became the main competitor of Polycom after it purchased Tandberg TV of Norway. Tandberg is the undisputed global leader in the uniform collaborative communications market with around 40% market share. Cisco itself is a developer of high-end video conferencing solutions, mainly comprising custom-designed digital boardrooms for executives and boards to hold global meetings. The merged entity will definitely be a much bigger player in the industry.
Read the full Analyst Report on CSCO
Read the full Analyst Report on PLCM